Conference
Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open
Authors
Sands BE; Moss AC; Armuzzi A; Marshall JK; Lindsay JO; Sandborn WJ; Danese S; Tsilkos K; Lawendy N; Zhang H
Volume
12
Pagination
pp. S49-S49
Publisher
OXFORD UNIV PRESS
Publication Date
February 1, 2018
Conference proceedings
JOURNAL OF CROHNS & COLITIS
ISSN
1873-9946